Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain-Reference-Cited by-同舟云学术

Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain

Published:1991-05 Issue:1 Volume:104 Page:106-112
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Herman Z. S.,Huzarska M.,Kmieciak-Kołada K.,Kowalski J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/BF02244563.pdf

Reference60 articles.

1. Anden NE, Butcher SG, Corrodi H, Fuxe K, Ungestedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303–314

2. Blanc D, Cupo A, Canastas E, Bourhins N, Giraud P, Bannon MJ, Eiden LE (1985) Influence of acute subchronic and chronic treatment with neuroleptic (haloperidol) on enkephalins and their precursors in the striatum of rat brain. Neuropeptides 5:567–570

3. Burt D, Creese I, Snyder S (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326–328

4. Bylund DB (1981) Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors. J Pharmacol Exp Ther 217:81–86

5. Cohen BH, Lipinski JF (1986) In vivo potencies of antipsychotic drugs in blocking alpha1 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of actions. Life Sci 39:2571–2580

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The differential contribution of dopamine D1 and D2 receptors to μ-opioidergic immunomodulation;Neuroscience and Behavioral Physiology;2007-09

2. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rats: a study of unlabeled and enkephalin-labeled striatal terminals;Journal of Neural Transmission;2003-09-01

3. Further Evidence that Behavioral Tests and Neuropeptide mRNA and Tissue Level Alterations Can Differentiate between Typical and Atypical Antipsychotic Drugs;Neuropsychopharmacology;2000-07

4. Effect of 6-hydroxydopamine on neuropeptide Y and corticotropin-releasing factor expression in rat amygdala;Neuroscience;1999-11

5. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat;European Neuropsychopharmacology;1999-01